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INTRODUCTION
The objectives of axillary lymph node dissection in
breast cancer surgery are to provide reliable informa-
tion regarding the number of pathological lymph node
metastases (pN) and to thereby prevent axillary lymph
node recurrence. At present, level I and II dissection is
recommended as the standard technique for axillary
lymph node dissection.
However, this dissection is associatedwith such com-
plications as swelling of the arm on the dissected side.
As a result, sentinel lymph node biopsy is currently
undergoing clinical trials as a new technique at various
institutions. However, radioisotopes (RI)must be used
in combination with sentinel lymph node biopsy in
order to elevate the accuracy rate.Thismeans that sen-
tinel lymph node biopsy can be applied only athospitals
which are equipped to use RI techniques.
In view of this situation, thepresent authors conceived
of and have carried out lower axillary dissection in
breast cancer surgery. As described herein, we have
found that this technique results in fewer complications
while also providing accurate prognostic information.
SUBJECTS AND METHODS
(STUDY 1)
The 28 examples in the personwhocarriedout the pri-
mary breast cancer operation which entailed axillary
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lymphnode dissection in the east Tokushima hospital
from 1997 by January, 2001 were made the target. It
is because the reason why lower axillary dissection
was carried out was the advanced age of seventy years
old and over 12 cases, a preoperative stage was Stage
0 -I 15 cases, a dialysis patient 2 cases. Our technique
for lower axillary dissection is as follows.
The second intercostobrachial nerve passes out of
the thoracic cavity and runs across the axillary region in
the direction of the upper arm. Using this as the bound-
ary, the axillary lymph nodes are divided into upper
and lower sets. The lower lymph nodes are dissected
to the inner edge of the smaller pectoralmuscle, thus
including both the level I and level II elements (Fig. 1).
The 28 patients showed an age range of 36-75 years
(mean : 60.1 years), with clinical staging showing
Stage 0 in 7 cases, Stage I in 14 cases and Stage II in
7 cases.
(STUDY 2)
Between April of 2000 and January of 2001, 58 pa-
tients underwent surgery for primary breast cancer
accompanied by axillary lymph node dissection in
Higashi TokushimaNational Hospital. After exclusion
of four patients in whom lower axillary dissectionwas
not carried out because of an abnormal course of the
second intercostobrachial nerve, 54 patients were in-
cluded in this study.
Following the usual procedure for level I and II node
dissection, first lower axillary dissection is carried out,
and then the level I & II lymph nodes remaining in the
upper set are dissected. Thus, level I and II lymph nodes
are completely dissected. Then the results of exami-
nation of the lymph nodes removed by the lower ax-
illary dissection and those removed by the level I and II
node dissection were compared.
The 54 patients showed an age range of 30-72 years
(mean: 50.5 years), with clinical staging showing Stage
I in 19 cases, Stage II in 31 cases and Stage III in 4 cases.
Clinical pathological staging was performed in
accordance with the TNMClassification ofMalignant
Tumours (Fifth Edition) published by theUICC. This
method was carried out under enough informed con-
sent to the patient made the target.
Fig. 1. Diagram of the axillary region after lower axillary dissection (right side)
1. Larger pectoral muscle ; 2. Axillary vein ; 3. Intercostobrachial nerve ;
4. Thoracodorsal nerve ; 5. Smaller pectoral muscle ; 6. Lateral thoracic artery stump ;
7. Long thoracic nerve ; 8. Serratus anterior muscle
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RESULTS
(STUDY 1)
The classification of dissected axillary lymph nodes
in the lower axillary dissection showed a range of 2-14
(mean : 7.6). An observation period after the operation
was 50-100 months (mean : 60.8 months). Complica-
tions were the pain of the operated arm (3 cases), pool-
ing of effusion toaxiller (1 case), andaxillary lymphnodes
recurrence (1 case). Swelling of the operated arm
wasn’t seen (Table 1).
(STUDY 2)
The classification of dissected axillary lymph nodes
in the lower axillary dissection showed a range of 3-13
(mean : 6.5), while in the level I and II node dissection
the range was 6 -23 nodes (mean : 14.8).
Comparison of Pathological Classification of Lymph
Node Metastases (pN) in Lower Axillary Dissection and
Level I and II Node Dissection (Table 2)
Both the lower axillary dissection and the level I and
II node dissection revealed 32 cases to be pN0. In ad-
dition, there were no cases diagnosed as pN0 on the
basis of the lower axillary dissection but positive for
metastasis based on the level I and II node dissection.
On the other hand, three caseswerediagnosedaspN1bi
on the basis of the lower axillary dissection but pN1bii
in the level I and II nodedissection.For the total 54 cases,
the rate of agreement for pNbetween the lower axillary
dissection and the level I and II node dissection was
94%. The sensitivity and specificity of lower axillary
dissection were each 100% with the pN0 case and the
pN1bi case, specificity was100%and sensitivity was
70% with the pN1bii case (Table 3).
Comparison of Pathological Classification of Lymph
Node Metastases (pN) in Lower Axillary Dissection and
Level I and II Node Dissection as functionofpreoperative
disease stage (Table 4)
Nineteen cases were classified as Stage I, and the
rate of agreement for pN between the lower axillary
Table 1. Complications of lower axillary dissection
Pain of the operatid arm 3
Pooling of effusion to axiller 1
Swelling of the operated arm 0
Axillary lymphnodes recurrence 1
An observation period after the operation was 50 -100 months
(mean : 60.8 months).
Table 2. Status of Metastasis-Positive LymphNodes (All Cases)
Low LevelI and II
No. of
patients
0 0 32
(Diagnostic accuracy rate 94%) 0 1-3 0
1-3 1-3 12
1-3 ＞3 3
＞3 ＞3 7
total 54
The status of metastasis-positive lymphnodes (pN), determined
by postoperative histopathological studies, was compared be-
tween the lower axillary dissection and level I and II dissection
methods. The absence of positive nodeswas classified as pN0,
whereas 1-3 positive nodes were classified as pN1bi and 4 or
more (＞3) positive nodes were classified as pN1bii. The di-
agnostic accuracy rate (94%) shows the percentage of cases for
which the findings were the same with both the lower axillary
dissection and level I and II dissection methods.
Table 3. Sensitivity and specificity of lower axillary dissection
(All Cases)
pN0 pN1bi pN1bii
Sensitivity 100 100 70
Specificity 100 100 100
Table 4. Status of Metastasis-Positive LymphNodes (as Function
of Preoperative Disease Stage)
Low LevelI & II
No. of
patients
Stage I 0 0 16
(Diagnostic accuracy rate 100%) 0 1-3 3
total 19
Stage II 0 0 16
(Diagnostic accuracy rate 90%) 1-3 1-3 8
1-3 ＞3 3
＞3 ＞3 4
total 31
The cases were stratified as a function of their preoperative
disease stage (Stage I or Stage II), and comparison of the
number of metastasis-positive lymphnodes (pN) found by the
lower axillary dissection and level I and II dissection methods
was performed as described in Table 1.
Table 5. Sensitivity and specificity of lower axillary dissection
(as Function of Preoperative Disease Stage)
pN0 pN1bi pN1bii
Stage I Sensitivity 100 100 ‐
Specificity 100 100 ‐
Stage II Sensitivity 100 100 57
Specificity 100 100 100
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dissection and the level I and II node dissection was
100%. The sensitivity and specificity of lower axillary
dissection were 100% each (Table 5).
Thirty-one cases had Stage II disease. Both the lower
axillary dissection and the level I and II node dissection
indicated 16 of those cases to be pN0, eight cases to
be pN1bi and four cases to be pN1bii. On the other
hand, three caseswere evaluated as p1Nbi by the lower
axillary dissection but pN1bii by the level I and II node
dissection. Accordingly, the lower axillary dissection
and the level I and II node dissection showed a 90% rate
of agreement for the pN status of the 31 Stage II cases.
The sensitivity and specificity of lower axillary dissec-
tion were each 100% with the pN0 case and the pN1bi
case, specificity was 100% and sensitivity was 57%with
the pN1bii case (Table 5).
Comparison of Pathological Classification of Lymph
Node Metastases (pN) in Lower Axillary Dissection
and Level I and II Node Dissection as function of pre-
operative lymph nodes status (Table 6)
Thirty of the patients were clinically diagnosed as
being free of axillary lymph node metastases. Seven
of these patients were found to be histologically positive
for lymph node metastases, but the lower axillary dis-
section and the level I and II node dissection showed
a 100% rate of agreement for the pN status of these 30
cases. The sensitivity and specificity of lower axillary
dissection were 100% each (Table 7).
Twenty-four of the patients had been clinically di-
agnosed as positive for axillary lymph nodemetastases
prior to the operation. Histologically, nine of those pa-
tients were found to be free of axillary lymphnodeme-
tastases, and the degree of agreement between the
lower axillary dissection and the level I and II node dis-
section on the pN status of these cases was 100%. In
three patients, the number of metastatic axillary lymph
nodes was 3 or less according to the lower axillary dis-
section but 4 ormore according to the level I and II node
dissection. Therefore, for these cases clinically diag-
nosed as having lymphnodemetastases (N1), the agree-
ment rate between the lower axillary dissection and
the level I and II node dissection on the pN status was
88%. The sensitivity and specificity of lower axillary
dissection were each 100% with the pN0 case and the
pN1bi case, specificity was 100% and sensitivity was
70% with the pN1bii case (Table 7).
DISCUSSION
Following the 1977 report by Fisher et al. (2) of their
randomized clinical trial, Donegan (3) reported that
axillary lymph node dissection did not contribute to
improving the survival results inbreast cancer patients.
Since then, the objectives of axillary lymph node dis-
section have been as an aide in estimation of the prog-
nosis and for limiting local axillary recurrence. In ad-
dition, it has been reported that there are no differ-
ences in the survival rate betweenstandard radicalmas-
tectomy and modified radicalmastectomy (3 ,4).More-
over, in 1991, NIH Consensus Conference (5) released
a recommendation that the standard treatment for
breast cancer should be simplemastectomy plus level
I and II axillary lymph node dissection. However, level
I and II axillary lymph node dissection causes various
complications, such as swelling of the arm on the dis-
sected side, pain, etc. Other problems exist, including :
skip metastases to level III in 3% of patients (6), and
these cannot be diagnosed by level I and II axillary lymph
node dissection ; patients who arepositive formetastases
at levels I and II are often found to have metastasis to
level III (6), but these are not dissected and can result
in under-staging. Accordingly, sentinel lymph node
biopsy is currently undergoing clinical trials as a new
technique at various institutions.
The principal advantages of sentinel lymph node
Table 6. Status of Metastasis-Positive LymphNodes (as Function
of Preoperative Lymph Node Status)
Low LevelI and II
No. of
patients
N0 0 0 23
(Diagnostic accuracy rate 100%) 1-3 1-3 7
total 30
N1 0 0 9
(Diagnostic accuracy rate 88%) 1-3 1-3 5
1-3 ＞3 3
＞3 ＞3 7
total 24
The cases were stratified as a function of their preoperative
lymph node metastasis status (N0 or N1), and comparison of
the number of metastasis-positive lymph nodes (pN) found
by the lower axillary dissection and level I and II dissection
methods was performed as in Table 1.
Table 7. Sensitivity and specificity of lower axillary dissection
(as Function of Preoperative Lymph Node Status)
pN0 pN1bi pN1bii
N0 Sensitivity 100 100 ‐
Specificity 100 100 ‐
N1 Sensitivity 100 100 70
Specificity 100 100 100
The Journal of Medical Investigation Vol. 52 February 2005 ７７
biopsy are as follows. It reduces postoperative com-
plications because itmakes it possible to avoid unnec-
essary axillary lymph node dissection in patients who
are found to be negative for axillary lymph node me-
tastasis. It also enables diagnosis of skip metastases.
Third, this technique makes it possible to achieve ac-
curate staging of node-positive breast cancer patients
because it involves dissection to level III. Finally, sen-
tinel lymph node biopsy makes it possible to control
local recurrence. By virtue of these attributes, it is an-
ticipated that sentinel lymph node biopsy will become
the standard technique in the future. A 75% diagnostic
accuracy rate was reported for sentinel lymph node
biopsy when the dyemethodwas used alone (7). Com-
bined use of the RImethod is becoming commonwith
the objective of elevating the accuracy rate, and a rate
of 93% was reported (7). However, combination of sen-
tinel lymph node biopsy and RI can only be carried
out at institutions that are equipped to handle these
hazardous materials, which makes it difficult for this
combined technique to be adopted inordinaryhospitals.
It was in consideration of this background situation
that we conceived of the lower axillary dissection ap-
proach for the management of breast cancer patients.
Our concept is an adaptation of two earlier-reported
methods : pectoral node biopsy, proposed by Forrest
et al ., in 1982 (8), and lower axillary sampling, reported
by Steele et al., in 1985 (9). That is, our technique entails
dissection, not sampling. At the time of those earlier
reports, it was thought that sampling was sufficient
for estimating the prognosis, but a subsequent report
stated that at least 10 lymph nodes had to be examined
in order to make an accurate estimate of the prognosis
(10). As a result, those earliermethods did no become
standard approaches. In our present technique of lower
axillary dissection, the objectives of carrying out dis-
section of the lower axillary lymph nodes rather than
mere sampling are to increase the number of resected
lymph nodes and to conserve the main lymph canals,
which areknown fromexperience to run from theupper
arm cephalic to the intercostobrachial nerve. In fact,
prior to the present study, we carried out a comparison
of the postoperative complications after lower axillary
dissection and after level I and II dissection.
That comparison revealed that the incidence of post-
operative swelling of the operated armshoweda range
of 2.7-5.0% after level I & II dissection versus a range
of 0-2.8% after lower axillary dissection. Postoperative
swelling didn’t happen to every patient by STUDY 1.
And, the place where it recurred is level III with one
person who brought about lymph node recurrence.
As for the side effect which is characteristic of lower
axillary dissection, it doesn’t think easily.
In our present study of 54 breast cancer patients in
whom loweraxillarydissectionwasable tobeperformed,
the number of axillary lymph nodes dissected showed a
range of 3-13(mean : 6.5) in the lower axillary dissection
and a range of 6-23(mean:14.8) in the level I and II dis-
section. The diagnostic accuracy rate for the total 54
patients was 94%, which is superior to the 90% reported
for the sampling method (8). In addition, in the case
of sentinel lymph node biopsy, the rate of detection
of the sentinel lymph node was 75% when using the
dye method alone, whereas it was 93%when combined
with use of anRI (7). Thus, the lower axillary dissection
approach can be considered to be more accurate. Fur-
thermore, it has been reported that the false-positive
rate with sentinel lymph node biopsy is 4.5-5.6% (7),
and in consideration of this, as well, it can be thought
that our 94% diagnostic accuracy rate bymeans of lower
axillary dissection compares favorably with the results
obtained by sentinel lymph node biopsy.Recently, there
is a report that five node biopsy from the surroundings
of the sentinel lymph node in the early breast cancer
was effective (11). Inparticular, ourpresent study showed
100% accuracy rate, sensitivity, and specificity in the
diagnosis of clinical Stage I breast cancer cases and
cases with a clinical classification of N0. Moreover,
the three cases which were under-staged (Table 8) in
this studywere each Stage IIB cases showing T2N1M0.
These findings also indicate the potential of lower ax-
illary dissection to replace level I and II dissection, es-
Table 8. Three Cases of Under-Staging
Preoperative Status Lymphnode Metastasis Status
T N Stage Low(+) / Low(all) LevelI and II(+) /
Level
I and II(all)
2 1 II B 1 / 3 8 / 18
2 1 II B 3 / 4 4 / 10
2 1 II B 3 / 3 4 / 13
Three cases were unders-staged by the lower axillary dissection method compared with the level I and II dissectionmethod. None
of these cases had preoperative distant metastases (M0).
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pecially in Stage 0 and Stage I cases of breast cancer.
Regarding the procedures to be applied after per-
forming lower axillary dissection, for cases found to
be node-positive by frozen sample diagnosis during
the operation, complete dissection should be performed
to level III. For node-negative cases, the subsequent
procedures are the same as for cases found to be node-
negative by level I and II dissection. Itwill bebest to per-
form follow-up observation of the axillary region by
ultrasound examinations.
Thus, lower axillary dissection is seen to havemany
advantages, such as that it does not require any spe-
cial facilities or equipment, it results in few complica-
tions and it affords a high diagnostic accuracy rate.
However, it must be noted that some problems remain
with the lower axillarydissectionapproach.Forexample,
the number of lymph nodes to be dissected can vary
between individual patients as a result of differences
in the location of the delineating intercostobrachial
nerve, while the technique does not permit diagnosis
of skip metastases.
It is hoped that the future will bring about a more
thorough understanding of themammary gland lymph
flow, and that it will be possible to establishadissection
method which is even safer, more broadly applicable
and causes fewer complications than the currently
available techniques.
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